GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 26 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 6.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1 | -50.0% | 3,000 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $2 | -99.8% | 3,000 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 3,000 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $2,000 | -60.0% | 3,000 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $5,000 | 0.0% | 3,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $5,000 | -37.5% | 3,000 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $8,000 | -11.1% | 3,000 | 0.0% | 0.00% | -25.0% |
Q2 2021 | $9,000 | -10.0% | 3,000 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $10,000 | – | 3,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ibex Investors LLC | 418,000 | $5,676,000 | 3.15% |
Knoll Capital Management, LLC | 210,000 | $2,881,000 | 2.44% |
BVF INC/IL | 1,761,567 | $23,922,000 | 2.10% |
P.A.W. CAPITAL CORP | 90,000 | $1,222,000 | 1.30% |
683 Capital Management, LLC | 1,350,000 | $18,333,000 | 1.19% |
Vivo Capital, LLC | 851,492 | $11,563,000 | 1.16% |
MEITAV INVESTMENT HOUSE LTD | 653,957 | $8,946,000 | 0.44% |
Trellus Management Company, LLC | 16,711 | $227,000 | 0.33% |
Nantahala Capital Management | 838,674 | $11,389,000 | 0.31% |
MENTA CAPITAL LLC | 49,183 | $668,000 | 0.23% |